Topics
Care Delivery
Care Management
Clinical AI
Dental Solution
Digital Health
Digital Systems
EMR-EHR
Facilities Management
Healthcare AI
Healthcare Analytics
Healthcare Cloud
Healthcare Marketing
Healthcare Risk and Compliance
Healthcare Workforce Management
Medical Imaging
Medical Practice Management
Mental and Behavioral Health
Obesity & Metabolic
Patient Engagement
Patient Monitoring
Pharmacy Management
Revenue Cycle Management
Therapy Management Solution
Veterinary Solution
CXO Insights
Vendor Viewpoint
News
Conferences
Partners
CXO Awards
About Us
Menu
Menu
US
EUROPE
APAC
LATAM
Alex D'souzaManaging Editoreditor@healthcaretechoutlook.comOne cannot fight fire blindfolded. And the same holds true when the healthcare sector has to fight a global pandemic and ensure that the global population stays healthy. Notably, proper diagnosis of diseases has always played a vital role in the timely treatment of diseased individuals. To this extent, genetic diagnoses have been on the rise for the past few years for better and personalized healthcare. Now, with the novel human coronavirus outbreak, genetic diagnostics is suddenly put on the fast lane.Diagnostic testing is potentially the only efficient way to monitor and combat the spread of COVID-19. In addition to enhancing the existing processes--such as molecular diagnostics (MDx), lateral flow assays (LAFs), and reverse transcription-polymerase Chain Reaction (qPT-PCR)--the need for universal and massive testing across the population has led to a race for technology innovations for COVID-19 diagnostics. Besides, multiple software companies are also developing algorithms to identify signs of COVID-19 related pneumonia in patient scans. Notably, these innovations that are currently proliferating the current market of genetic diagnostics are going to be mainstay even in the post-COVID-19 world, thereby facilitating an unprecedented digitally-enabled genetic diagnostic system.In this edition of Healthcare Tech Outlook, we bring you the story of some of the most successful genetic diagnostic companies that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best genetic diagnostic solutions according to your requirements. Let us know your thoughts!Diving Deeper within Human GenomesEditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark RobertVisualizerUTLOOKHealthcare Tech Copyright© 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.AUGUST - 10 - 2020, volume 06 - Issue 19 (ISSN 2691-3933) Published by ValleyMedia, Inc. To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com UTLOOKHealthcare Tech *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comPhone:510.972.5010Fax:510-894-8405Contact Us:ImmanuelJaxon JaseSalesRich Gonsalves rich@healthcaretechoutlook.com
<
Page 5
|
Page 7
>